Recruiting

Support Platform

Sponsor:

McGill University

Code:

NCT06069583

Conditions

Type 1 Diabetes

Metabolic Disease

Endocrine System Diseases

Autoimmune Diseases

Immune System Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Support platform

Study Details

Brief summary:

The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the "Support" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration "Support" in clinical care.

Conditions

Type 1 Diabetes

Metabolic Disease

Endocrine System Diseases

Autoimmune Diseases

Immune System Diseases

Study ID

NCT06069583

Start date

May 5, 2024

Status verified date

Sep, 2025

Completion date

Oct, 2027

Anticipated

Primary completion date

May 5, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)
  • Have access to Internet
  • Use of an active email address
  • Comprehension of English or French
  • Live in Canada

Exclusion Criteria:

\- Unable to use the Support platform

Study Design

Enrollment

322 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Support integrated in usual care

PWT1D participants will have access to Support as part of their regular care (their HCPs will use Support in their care). PWT1D participants in ARM 1 are followed in one of the 4 participating clinics either in-person or remotely or hybrid.

active comparator: Support through independent access

PWT1D participants will have access to Support, independently from their regular care (they may initiate discussion about the platform with their diabetes care team who might register themselves on the platform, but will not prompt to any specific section on the platform and will not receive any training about the platform). PWT1D participants in ARM 2 can be followed in any other clinics in Canada.

Interventions

Support platform

The study will be conducted over a 12-month period. This should allow participants to see their medical team 2 to 3 times during this timeframe. Participants of arms 1 and 2 will have access to the Support platform and will receive a monthly newsletter, informing them of news on the platform and acting as a reminder to log in. Several features are included in this responsive-designed platform to enhance participation, such as a visual of personal progress, ability to bookmark content, change their avatar.

Support contains 3 main components: Educational material, News blog written by HCPs weekly in collaboration with patient-partners on up-to-date topics related to T1D, a peer-to-peer discussion forum which is moderated daily by a HCP specializing in T1D.

Primary outcome measure

  • Self-efficacy for diabetes management [ Time Frame: 0, 6 and 12 months ]

Central Contacts and Locations

Central contacts

Anne-Sophie Brazeau, PhD

5143987848anne-sophie.brazeau@mcgill.ca

amelie Roy-Fleming, MSc

5147790749amelie.roy-fleming@mcgill.ca

Locations

Institut de recherches cliniques de Montréal

Recruiting

Montreal, Quebec, Canada, H2W 1R7

Contacts

Marie Devaux

5149875500type1support@mcgill.ca

Centre hospitalier de l'université de Montreal

Recruiting

Montreal, Quebec, Canada, H2X 0C1

Contacts

Ann Gobeil

514-890-8000type1support@mcgill.ca

Centre hospitalier de Quebec, Université Laval

Recruiting

Québec, Quebec, Canada, G1V 0E8

Contacts

Claudia Huard

418-525-4444type1support@mcgill.ca

Centre de médecine métabolique de Lanaudière

Recruiting

Terrebonne, Quebec, Canada, J6x 4P7

Contacts

Tammy Cadieux

514-907-5101type1support@mcgill.ca

More Information

Sponsor

McGill University

Last update posted

Sep 25, 2025

Last verified

Sep, 2025

Keywords

  • self-management education
  • Hemaglobin A1c
  • Online education
  • adults
  • type 1 diabetes

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University on 2025-09-25.